Skip to main content

Table 2 Comparison of parameters between continence and incontinence patients at 1 and 3 months after operation

From: Urinary continence outcomes of four years of follow-up and predictors of early and late urinary continence in patients undergoing robot-assisted radical prostatectomy

Variable

1 Month

3 Months

Continence (N = 264)

Incontinence (N = 386)

P value

Continence (N = 396)

Incontinence (N = 254)

P value

Age (years)

65.60 ± 7.04

65.63 ± 7.94

0.959

65.20 ± 7.32

66.27 ± 7.94

0.080

BMI (kg/m2)

24.85 ± 2.75

25.14 ± 2.98

0.209

25.01 ± 2.82

25.02 ± 3.01

0.964

Comorbidities, no (%)

 HP

77 (29.17%)

141 (36.53%)

0.051

122 (30.81%)

96 (37.80%)

0.066

 DM

38 (14.39%)

77 (16.06%)

0.563

64 (16.16%)

36 (14.17%)

0.493

 CHD

20 (7.58%)

43 (11.14%)

0.131

38 (9.60%)

25 (9.84%)

0.917

 CD

9 (3.41%)

11 (2.85%)

0.685

10 (2.53%)

10 (3.94%)

0.309

 PSA (ng/mL)

27.65 ± 32.92

32.11 ± 36.08

0.109

28.65 ± 32.17

32.86 ± 38.64

0.133

 PV (mL)

37.73 ± 20.20

35.80 ± 18.58

0.211

37.15 ± 19.34

35.70 ± 19.15

0.348

 Gleason score, no (%)

  

0.475

  

0.654

 ≤6

79 (29.92%)

114 (29.53%)

 

117 (29.55%)

76 (29.92%)

 

 7

95 (35.98%)

160 (41.45%)

 

151 (38.13%)

104 (40.94%)

 

 ≥8

78 (29.55%)

97 (25.13%)

 

113 (28.54%)

62 (24.41%)

 

 Unknown

12 (4.55%)

15 (3.89%)

 

15 (3.78%)

12 (4.73%)

 

 Clinical T stage, no (%)

  

0.962

  

0.550

 T1a,b

1 (0.37%)

1 (0.26%)

 

1 (0.25%)

1 (0.39%)

 

 T1c

46 (17.42%)

68 (17.62%)

 

69 (17.42%)

45 (17.72%)

 

 T2a,b

102 (38.64%)

139 (36.01%)

 

157 (39.65%)

84 (33.07%)

 

 T2c

103 (39.02%)

155 (40.16%)

 

149 (37.63%)

109 (42.91%)

 

 T3a

1 (0.37%)

2 (0.51%)

 

1 (0.25%)

2 (0.79%)

 

 T3b

11 (4.17%)

21 (5.44%)

 

19 (4.80%)

13 (5.12%)

 

 OT (mins)

151.61 ± 42.16

153.81 ± 48.78

0.551

151.02 ± 41.76

155.86 ± 52.30

0.192

 NS, no (%)

73 (27.65%)

48 (12.44%)

0.000

87 (21.97%)

34 (13.39%)

0.045

 PLND, no (%)

121 (45.83%)

217 (56.22%)

0.009

204 (51.52%)

134 (52.76%)

0.757

 DIC (days)

21.22 ± 10.83

21.02 ± 10.09

0.810

21.28 ± 11.46

20.84 ± 8.46

0.601

  1. Abbreviations: BMI Body mass index, CHD Coronary heart disease, CD Cerebrovascular diseases, DM Diabetes mellitus, DIC Duration of indwelling catheter, HP Hypertension, NS Nerve-sparing, OT Operation time, PSA Prostate-specific antigen, PV Prostate volume, PLND Pelvic lymph node dissection